SEC Form 4 · accession 0001547522-15-000107
OxySure Therapeutics, Inc. · OXYS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Julian T Ross
Officer — CEO · Director · 10% Owner
Period of report
May 27, 2015
Accepted (ET)
May 27, 2015 · 4:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001413797
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 27, 2015 | P | 5,100 | $0.6826 | A | 151,124 | D | |
| Common Stock | holding | — | — | — | 14,040,761 | I | Held by JTR Investments, Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Aggregate purchase price for 5,100 shares purchased on the open market through various purchases on May 27, 2015.